ÂÜÀòÂÒÂ×

Dawn Spaulding is a Strategic Finance Executive with a robust background in financial planning and analysis across multiple industries, including biotech. They served as Finance Director at BioMarin Pharmaceutical Inc. from 2016 to 2022, where they directed financial planning and reporting while advising senior leadership on strategic business decisions. Previously, they held various finance roles, including Senior Finance Manager and Financial Analyst, where they excelled in budgeting and forecasting activities. Dawn is currently pursuing a Master's in Business Administration at the University of San Francisco and holds a Bachelor's degree in Economics from the University of California, Los Angeles.